Ocugen Inc (NASDAQ:OCGN)
| 6.60 BATS BZX Real-Time Price As of 1:30pm ET |  +0.12 / +1.85%Today’s Change | 0.28 Today|||52-Week Range 18.77 | +260.66% Year-to-Date |
Latest OCGN News | Press Releases
| 3 Small-Cap COVID Stocks With Huge Upside Nov 25 / MotleyFool.com - Paid Partner Content | The Biggest Problem With Moderna Has Nothing to Do With Its Recent Earnings Miss Nov 18 / MotleyFool.com - Paid Partner Content |
| Better Buy: Ocugen or Novavax? Nov 24 / MotleyFool.com - Paid Partner Content | Why This Meme Stock Isn't Worth the Trouble Nov 18 / MotleyFool.com - Paid Partner Content |
| Battle of the COVID Vaccine Contenders: Inovio vs. Ocugen Nov 21 / MotleyFool.com - Paid Partner Content | 3 Biotech Stocks That Have More Than Tripled so far This Year Nov 18 / MotleyFool.com - Paid Partner Content |
| Ocugen Stock: Bull vs. Bear Nov 20 / MotleyFool.com - Paid Partner Content | 3 Things About Ocugen That Smart Investors Know Nov 17 / MotleyFool.com - Paid Partner Content |
| Why Ocugen Shot 8% Higher on Friday Nov 19 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.48 |
| Today’s open | 6.73 |
| Day’s range | 6.43 - 6.74 |
| Volume | 309,148 |
| Average volume (3 months) | 26,657,476 |
| Market cap | $1.3B |
Data as of 1:30pm ET, 11/29/2021
Growth & Valuation
| Earnings growth (last year) | +78.98% |
| Earnings growth (this year) | +3.23% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 4,819.15 |
| Price/Book | 54.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGNXRegenxbio Inc | -0.01 | -0.03% |
| QUREUniqure NV | +0.13 | +0.45% |
| SGMOSangamo Therapeutics... | -0.03 | -0.35% |
| MORMorphoSys AG | +0.14 | +1.41% |
Data as of 1:30pm ET, 11/29/2021
Financials
| Next reporting date | April 1, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $42.6K |
| Annual profit (last year) | -$21.8M |
| Net profit margin | -51,201.20% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Malvern, Pennsylvania |
Forecasts
